Suven Life Sciences Ltd Q1FY23 consolidated loss at Rs. 16.32 crores

Suven Life Sciences Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 3.9750 crores during the period ended June 30, 2022 as compared to Rs. 4.3395 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. -16.3262 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -20.7981 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. -1.12 for the period ended June 30, 2022 as compared to Rs. -1.63 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 3.9750 crs	₹4.3395 crs	-8.40%
Net Profit	₹-16.3262 crs	₹-20.7981 crs	21.50%
EPS	₹-1.12	₹-1.63	31.29%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 3.9750 crores during the period ended June 30, 2022 as compared to Rs.2.8456 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.-16.3262 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-39.2085 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.-1.12 for the period ended June 30, 2022 as compared to Rs.-3.08 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 3.9750 crs	₹2.8456 crs	39.69%
Net Profit	₹-16.3262 crs	₹-39.2085 crs	58.36%
EPS	₹-1.12	₹-3.08	63.64%

Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 70.50 as compared to the previous close of Rs. 71.30. The total number of shares traded during the day was 12518 in over 523 trades.

The stock hit an intraday high of Rs. 71.40 and intraday low of 69.75. The net turnover during the day was Rs. 881786.00.

Source : Equity Bulls

Keywords

SuvenLifeSciences Q1FY23 ResultUpdate